apl. Prof. Dr. Manfred Marschall

Medizinische Fakultät

The complex regulatory role of cytomegalovirus nuclear egress protein pul50 in the production of infectious virus (2021) Häge S, Büscher N, Pakulska V, Hahn F, Adrait A, Krauter S, Borst EM, et al. Journal article IMU-838, a small molecule DHODH inhibitor in phase II clinical trial for multiple sclerosis, shows potent Anti-EBV activity in cell-culture-based systems: Potential additional benefits in multiple sclerosis treatment (2021) Marschall M, Peelen E, Müller R, Wangen C, Wagner S, Muehler A, Groeppel M, et al. Conference contribution A placental specific miRNA miR-517a-3p exerts anti-human cytomegalovirus activity (2021) Hamilton ST, Hahn F, Sonntag E, Marschall M, Rawlinson WD Journal article Methodological development of a multi-readout assay for the assessment of antiviral drugs against sars-cov-2 (2021) Hahn F, Häge S, Herrmann A, Wangen C, Kicuntod J, Jungnickl D, Tillmanns J, et al. Journal article Functional Relevance of the Interaction between Human Cyclins and the Cytomegalovirus-Encoded CDK-Like Protein Kinase pUL97 (2021) Schütz M, Steingruber M, Socher E, Müller R, Wagner S, Kögel M, Sticht H, Marschall M Journal article, Original article Exploring the Human Cytomegalovirus Core Nuclear Egress Complex as a Novel Antiviral Target: A New Type of Small Molecule Inhibitors (2021) Alkhashrom S, Kicuntod J, Häge S, Schweininger J, Muller Y, Lischka P, Marschall M, Eichler J Journal article Properties of Oligomeric Interaction of the Cytomegalovirus Core Nuclear Egress Complex (NEC) and Its Sensitivity to an NEC Inhibitory Small Molecule (2021) Kicuntod J, Alkhashrom S, Häge S, Diewald B, Müller R, Hahn F, Lischka P, et al. Journal article Phenotypical Characterization of the Nuclear Egress of Recombinant Cytomegaloviruses Reveals Defective Replication upon ORF-UL50 Deletion but Not pUL50 Phosphosite Mutation (2021) Häge S, Sonntag E, Svrlanska A, Borst EM, Stilp AC, Horsch D, Müller R, et al. Journal article Combinatorial drug treatments reveal promising anticytomegaloviral profiles for clinically relevant pharmaceutical kinase inhibitors (PKIs) (2021) Wild M, Kicuntod J, Seyler L, Wangen C, Bertzbach LD, Conradie AM, Kaufer BB, et al. Journal article Investigational Antiviral Therapy Models for the Prevention and Treatment of Congenital Cytomegalovirus Infection during Pregnancy (2021) Hamilton ST, Marschall M, Rawlinson WD Journal article